Irritable Bowel Syndrome or Inflammatory Bowel Disease: Can Fecal Calprotection make the Difference? Case Study

Authors

  • A.G. Moraru Clinical Emergency County Hospital Brasov, Romania
  • M.M. Dinculescu ”Carol Davilla” University Bucharest, Romania
  • I.G. Moraru Gastroenterology and Hepatology Center Fundeni, Bucharest, Romania

Keywords:

fecal calprotectin, irritable bowel syndrome, inflammatory bowel disease

Abstract

Revue of literature and case study regarding the role of fecal calprotectin in differentiating irritable bowel syndrome from inflammatory bowel disease and monitoring the treatment outcome in IBD.

Author Biography

M.M. Dinculescu, ”Carol Davilla” University Bucharest, Romania

Fundeni Clinical Institute

Downloads

Published

2013-09-26

Issue

Vol. 6(55) No. 1 (2013)

Section

MEDICAL SCIENCES